Phase2Phase Biopharma AB

ABActive

Org 5593257131Economic activity was not specified by tax authority· NACE 0000Est. 2021 · 4 years old0 employees

Overview Financials People & ownership Related companies

Phase2Phase Biopharma AB is a Swedish AB, operating in the Economic activity was not specified by tax authority sector. Incorporated in 2021, the company has 0 employees and reported revenue of SEK -1 in its latest annual filing.

Revenue 2025

SEK -1

EBITDA margin

6023500.0%

-30% vs 2024

Net profit 2025

SEK 2M

+20% vs 2024

Key ratios

See full ratios →

98.4%

This company

20212025

61.1×

This company

20212025

86.5%

This company

20212025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK -1	—
EBITDA	SEK -60K	-30%
Net profit	SEK 2M	+20%
Total assets	SEK 2,3M	+28%
Equity	SEK 2,3M	+28%
Employees	0	—

Contact

Address

contact@phase2phase.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Phase2Phase Biopharma AB?

Phase2Phase Biopharma AB is registered with Bolagsverket / SCB under Org 5593257131.

What is the revenue of Phase2Phase Biopharma AB?

Phase2Phase Biopharma AB reported revenue of SEK -1 in 2025.

Who is the chairman of Phase2Phase Biopharma AB?

Svante Henrik Almkvist chairs the board of Phase2Phase Biopharma AB.

Phase2Phase Biopharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Phase2Phase Biopharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Phase2Phase Biopharma AB